feed,title,long_url,short_url
gNews,"2 biotech stocks plummet more than 25% after the FDA rejects their drug applications (GILD, GLPG, BMRN) - Business Insider",https://www.businessinsider.com/biomarin-galapagos-gilead-stock-price-fda-issues-crl-drug-rejection-2020-8,https://j.mp/2Q6Jej9
